Minimally Invasive Surgical Technique in Management of Intrabony Defects
1 other identifier
interventional
28
1 country
1
Brief Summary
In the fast-growing era of contemporary periodontology, the understanding of biological concepts in wound healing together with the evolution of the flap design and biomaterials applied in periodontal regeneration allowed for improved minimally invasive surgical techniques. As minimally invasive approaches reduce the surgical trauma, maintain soft tissue support which allow stable primary closure of the wound. These advantages have led more researchers to apply the concept of minimally invasive surgical techniques (MISTs) in the treatment of infrabony lesions. Granulation tissue is an immature connective tissue that appears naturally during chronic inflammation or wound healing. This tissue is not a cause of periodontitis. So, no need to remove it during periodontal treatment. The aim of preservation of the defect-filling granulation tissue after detachment of its base is assumed to act as a soft tissue support, and to increase wound stability especially in the area of the interdental papilla and avoid post-operative marginal recession. One of the alloplastic bone grafts is βeta tri-calcium phosphate (β-TCP). β-TCP has been widely used in periodontal regeneration, where many studies used beta tri-calcium phosphate alone or in combination with other grafting materials in different surgical regenerative procedures have shown promising results for bone filling and new vital bone formation. Hyaluronic acid gel shows anti-inflammatory, antibacterial, and antioxidant properties in the treatment of periodontal diseases. In addition, due to its viscoelastic properties, it can be used as an adjunct to maintain space during periodontal tissue regeneration. A concentration of 0.8% hyaluronic acid gel has been used effectively in the non-surgical and surgical management of periodontal diseases. Aim of The Study The aim of the present study is to evaluate the effects of the minimally invasive surgical technique with and without granulation tissue preservation using a combination of beta tri calcium phosphate and hyaluronic acid gel.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 2, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 5, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 21, 2024
CompletedFirst Submitted
Initial submission to the registry
September 8, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedSeptember 19, 2024
April 1, 2023
10 months
September 8, 2024
September 8, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Clinical attachment level
measured from cemento-enamel junction to the base of the pocket by using william's graduated periodontal probe
6 months
Study Arms (2)
Minimally invasive surgical technique with total removal of granulation tissue
ACTIVE COMPARATORMinimally invasive surgical technique with total removal of granulation tissue
Minimally invasive surgical technique with partial removal of granulation tissue
EXPERIMENTALMinimally invasive surgical technique with partial removal of granulation tissue
Interventions
minimally invasive surgical technique
minimally invasive surgical technique with granulation tissue preservation
Eligibility Criteria
You may qualify if:
- Patient age ranged from 30 to 50 years old for both genders.
- Patients are medically free according to the American society of anesthesiologists (ASA) considered as ASA I.
- The selected participants with a diagnosis stage III grade B periodontitis.
- Defect morphology: Isolated interproximal infrabony defect of at least 5mm CAL which does not extend beyond the adjacent interproximal region.
- Optimal compliance as assessed during the case related phase I therapy and evidenced by no missed treatment appointments and positive attitude toward oral hygiene.
- Bleeding on probing \<25%.
You may not qualify if:
- Smoker and pregnant patients.
- Multiple, interconnected vertical defects.
- Generalized horizontal bone defects.
- Teeth with incorrect endodontic treatment or restoration.
- Stage I, II or IV periodontitis.
- Patient who need complex prosthetic rehabilitation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tanta university
Tanta, Gharbia Governement, 6620010, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle investigator
Study Record Dates
First Submitted
September 8, 2024
First Posted
September 19, 2024
Study Start
May 2, 2023
Primary Completion
March 5, 2024
Study Completion
August 21, 2024
Last Updated
September 19, 2024
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share